Palisade Capital Management LLC Novo Cure LTD Transaction History

Palisade Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$60.15 - $84.52 $180,450 - $253,560	-3,000 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$75.08 - $121.99 $15,016 - $24,398	200 Added 7.14%	3,000 $225,000
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $325,276 - $544,740	2,800 New	2,800 $325,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Palisade Capital Management LLC with notifications on news.